England’s chief medical officer has said he believes “far too many people” who are not experts in medicine and science “have thrown far too many arguments” into the debate around a puberty blocker trial for children.
A clinical trial into the impacts of puberty blockers on children as young as 10 was launched in November but it was paused last month – before anyone had been recruited – amid concerns about the “unquantified risk” of “long-term biological harms”.
